baber/WOPTO huggingface dataset:
Patent NZ-271316-A (NZ)
Title: Fluoroalkoxy benzamide derivatives, pharmaceutical compositions
Inventor: AMSCHLER HERMANN
IPC: A61K31/44
Filed: 1994-07-02
Abstract: PCT No. PCT/EP94/02169 Sec. 371 Date Dec. 19, 1995 Sec. 102(e) Date Dec. 19, 1995 PCT Filed Jul. 2, 1994 PCT Pub. No. WO95/01338 PCT Pub. Date Jan. 12, 1995Compounds of formula (I), in which one of the substituents R1 or R2 stands for hydrogen, 1-6C-alkoxy, 3-7C-cycloalkoxy, 3-7C-cycloalkylmethoxy, benzyloxy or totally or partially fluorine-substituted 1-4C-alkoxy, and the other stands for totally or partially fluorine-substituted 1-4C-alkoxy, and R3 stands for phenyl, pyridyl, R31, R32 and R33-substituted phenyl or R34, R35, R36 and R37-substituted pyridyl, in which R31 stands for hydroxy, halogen, cyano, carboxyl, trifluoromethyl 1-4C-alkyl, 1-4C-alkoxy, 1-4C-alkoxycarbonyl, 1-4C-alkylcarbonyl, 1-4C-alkylcarbonyloxy, amino, mono- or di-1-4C-alkylamino or 1-4C-alkylcarbonylamino; R32 stands for hydrogen, hydroxy, halogen, amino, trifluoromethyl, 1-4C-alkyl or 1-4C-alkoxy; R33 stands for hydrogen, halogen, 1-4C-alkyl or 1-4C-alkoxy; R34 stands for hydroxy, halogen, cyano, carboxyl, 1-4C-alkyl, 1-4C-alkoxy, 1-4C-alkoxycarbonyl or amino; R35 stands for hydrogen, halogen, amino or 1-4C-alkyl; R36 stands for hydrogen or halogen; and R37 stands for hydrogen or halogen. These compounds constitute new effective bronchotherapeutic drugs.
Patent NZ-332656-A (NZ)
Title: Method and apparatus for measurement directed hard handoff in a CDMA system
Inventor: WEAVER LINDSAY A
IPC: H04W36/14
Filed: 1997-05-22
Abstract: In a communications network, a network user communicates using a remote unit (125) with another user (30) via at least one base station (B1A). The network includes first (MSC-I) and second (MSC-II) mobile switching control stations respectively controlling communications through a first set of base stations (B1A-B1E) including a first base station (B1A) and through a second set of base stations (B2A-B2E) including a second base station (B2A). To direct communications between the remote unit (125) and the first (B1A) and second base stations (B2A) the first base station (B1A) measures a round trip delay of an active communication signal between the first base station (B1A) and the remote unit (125). The remote unit (125) measures a first phase offset of a pilot signal received from a first candidate base station (B1A) and reports it to the first mobile switching center (MSC-I) via the first base station (B1A). The first mobile switching center (MSC-I) calculates a candidate round trip delay between the remote unit (125) and the first candidate base station (B1A) based on the first phase offset and the round trip delay of the active communication signal. An active communication control unit accesses a measurement directed hard handoff table to determine a location of the remote unit based on the round trip delay corresponding to the first active communication signal and the candidate round trip delay.
Patent NZ-333466-A (NZ)
Title: Self-cleaning rotary trash harrow with lateral main beam and sub-frame(s) extending rearwardly supporting a spiked roller with spikes on helical path around roller
Inventor: BROWN GARY JOHN
IPC: A01B21/04
Filed: 1997-05-23
Abstract: A self-cleaning rotary trash harrow comprising a main beam with for attachment to a prime mover to be drawn at right angles to the direction of travel at least one sub-frame fixed to the main beam and extending rearwardly therefrom the or each sub-frame supporting a spiked roller being typically at an angle of between 50° and 55° to the direction of travel. The spikes are affixed at locations lying on a helix around the roller, and the angle of the helix to the axis of the roller is typically between 50° and 55°. Typically the angle between the axis of each spike and axis of the roller is between 50° and 5°, to enable the axis of each spike to be parallel to the direction of travel when the spike passes through the horizontal plane at the trailing edge of the roller.
Patent NZ-333687-A (NZ)
Title: Phosphonomethoxy nucleotide analogs
Inventor: ARIMILLI MURTY N
IPC: C07F9/6561
Filed: 1997-07-25
Abstract: Phosphonomethoxy nucleotide analogs are provided having the above structure, wherein: B is guanin-9-yl, adenin-9-yl, 2,6-diaminopurin-9-yl, 2-aminopurin-9-yl or their 1-deaza, 3-deaza, or 8-aza analogs or B is cytosin-1-yl; R independently is H, C1-C6 alkyl, aryl, alkenyl, alkynyl, alkyenylaryl, alkynylaryl, alkaryl, arylalkynyl, arylalkenyl or arylalkyl which is unsubstituted or is substituted with halo, azido, nitro or OR3 in which R3 is C1-C12 alkyl; R2 independently is H, C1-C6 alkyl; R1 is independently H, alkyl, -CH2OH, -CH2F, -CH=CH2, or -CH2N3 or R1 and R8 form a methyl link; and R8 independently is -H or HR2-O-C(O)-OR or R8 and R1 form a methyl link. The compounds are useful as intermediates for the preparation of antiviral compounds or oligonucleotides, or are useful for administration directly to patients for antiviral therapy or prophylaxis.
Patent NZ-335642-A (NZ)
Title: Method for increasing fertilizer efficiency
Inventor: KINNERSLEY ALAN M
IPC: C05G5/23
Filed: 1997-11-04
Abstract: The specification describes combinations of fertilizer with certain organic compounds to increase fertilizer efficiency, plant productivity, growth, and nutrient accumulation. These beneficial effects are accomplished using combinations of a fertilizer and an amino acid selected from 'gamma'-aminobutyric acid (ranging from 50-1000 ppm), glutamic acid, and a mixture of g-aminobutyric acid and glutamic acid (ranging from 50-2000 ppm). A source of proteinaceous amino acids (ranging from about 50-1000 ppm) and a carbon skeleton (ranging from about 50-5000 ppm) may also be used with the fertilizer and the amino acid. The specification describes compositions and methods employing such combinations to take advantage of their beneficial effects.
Patent NZ-336676-A (NZ)
Title: Gemcitabine esters or amides useful as anti-cancer and anti-viral agents
Inventor: MYHREN FINN
IPC: A61K31/7068
Filed: 1998-01-23
Abstract: he invention provides Gemcitabine esters or amides in which the 3'- and/or 5'-OH group and/or the N4-amino group is derivatised with a C18- and/or C20- saturated or mono-unsaturated acyl group, preferably an acyl group selected from oleoyl, elaidoyl, cis-eicosenoyl and trans-eicosenoyl. The Gemcitabine esters and amides are useful as anti-cancer and anti-viral agents.
Patent NZ-337679-A (NZ)
Title: Dry powder inhaler with cartridge advanced by ratchet
Inventor: EISELE ROBERT
IPC: A61M16/00
Filed: 1998-03-16
Abstract: A dry powder inhaler is disclosed which has a lid (20) pivotally attached to an inhaler housing (5). The inhaler includes a mixing chamber (not shown), a medicine cartridge (60) and a pressure switch (not shown). A ratchet lever (not shown) on the housing (5) engages the lid (20) and the cartridge (60) for cartridge rotational advancement with movement of the lid.
Patent NZ-504724-A (NZ)
Title: Rotary piston pump or non-reciprocating Otto engine and method of operation
Inventor: SMITH ROGER JOHN
IPC: F01C1/04
Filed: 1998-11-25
Abstract: A work unit, such as a blower, compressor, supercharger or engine is shown with a main shaft (1) and a pair of pistons (3) mounted on respective shafts (4). The main shaft (1) and the shafts (4) are connected by gearing to hold the pistons in a stationary orientation relative to the axis of the main shaft and the housing (5). The main shaft has a pair of opposed part cylindrical recesses (55) to accommodate the respective pistons. The arcuate surfaces (R4) of the pistons cooperate with the concentric arcuate surface (R5) of the main shaft. As the shaft rotates, the edges (48) of the pistons can cooperate with the respective top and bottom arcuate surfaces (R1, R2) of the inner surface (49) of the housing on either side of the blades (53, 54), while the external arcuate surfaces (R4) of the piston can cooperate with the concentric arcuate surfaces (R3) of the internal surface (49) of the housing.
Patent NZ-505877-A (NZ)
Title: Oral delivery of nucleic acid vaccines by particulate complexes
Inventor: SAMPSON HUGH
IPC: A61K47/48
Filed: 1999-01-15
Abstract: The use of vaccine formulation comprising a solid nanoparticle of less than 5 ìm comprising a coacervate of a polymeric polycation and a polyanion, wherein the polyanion consists of nucleic acids encoding an antigen in the manufacture of a medicament for the treatment of immune responses, allergic responses, food allergies, IgE-medicated responses, inflammatory diseases, or osteoarthritis.
Patent NZ-507053-A (NZ)
Title: Cordless, high torque power tool has offset rotary sleeve for coupling attachment to the power input shaft
Inventor: GOUGE LLOYD V
IPC: H02K7/14
Filed: 1999-03-26
Abstract: A portable power tool (20) provides operating torque for a rotary load.  The portable power tool (20) includes an offset rotary sleeve (52) for coupling attachment to the power input shaft (39) of the rotary load.  A gearing assembly (46) provides right angle torque from an in-line DC motor (38).  The gearing assembly (48) is driven by an output power shaft (42) which is powered by a DC electrical motor (38).  The rotary sleeve (52) coupling is supported on opposite ends by a first bearing on an upper portion of the rotary sleeve coupling (52) and by a second bearing on a lower portion of the rotary sleeve coupling.  The DC motor (38) is powered by a rechargeable battery (32).
Patent NZ-508631-A (NZ)
Title: Substituted (dihydro) benzoxazine and (dihydro) benzothiazine compounds for treating disorders associated with the melatoninergic system specifically seasonal affective disorders and sleep disorders
Inventor: GUILLAUMET GERALD
IPC: C07D265/36
Filed: 2000-12-05
Abstract: Substituted (dihydro)benzoxazine and (dihydro)benzothiazine compounds with the general Formula (I), to a process for their preparation, and to pharmaceutical compositions containing them are described. The compounds and compositions are suitable for treating disorders related to the melatoninergic binding sites. Wherein; R1 represents a halogen atom or a group R, OR, SR, SO2NRR', -NRR', groups as shown as Formula (II); wherein Z represents a sulphur atom or an oxygen atom and R, R' and R", which are identical or different, represent a hydrogen atom or an unsubstituted or substituted, linear or branched C1-6alkyl group, an unsubstituted or substituted, linear or branched C2-6alkenyl group, an unsubstituted or substituted, linear or branched C2-6alkynyl group, an unsubstituted or substituted C3-8­cycloalkyl group, an unsubstituted or substituted C3-8cycloalkyl-C1-6alkyl group in which alkyl is linear or branched, an aryl group, an arylC1-6alkyl group in which alkyl is linear or branched, a heteroaryl group or a heteroaryl-C1-6alkyl group in which alkyl is linear or branched, and wherein (R and R') or (R' and R") may together form, with the nitrogen atom carrying them, a morpholinyl, piperidinyl, piperazinyl or pyrrolidinyl group); G represents an alkylene chain containing from 2 to 4 carbon atoms when A represents a group -C(Z)-N(R)-R' and from 1 to 4 carbon atoms in all other cases, G being optionally substituted by a group R, OR, COR or COOR; A represents a group of Formula (III); R2 represents a halogen atom or a group R, OR, COR, COOR or OCOR; X represents an oxygen atom or a sulphur atom.
Patent NZ-514391-A (NZ)
Title: Raised frozen dough stuffing
Inventor: ZHANG XIXIANG SUNNY
IPC: A21D6/00
Filed: 2001-09-25
Abstract: A raised frozen dough stuffing for use in stuffing poultry is described. The dough stuffing is comprised of leavening agents, flour and breadcrumbs, prepared by a dry and/or wet process and then frozen. The dough stuffing may also comprise flavouring agents such as herbs, spices, fruits and vegetables.
Patent NZ-515737-A (NZ)
Title: Side multiple-lamp on-line inside quality inspecting device
Inventor: NAGAYOSHI ATSUHIRO
IPC: G01N21/59
Filed: 2000-06-20
Abstract: An object (F) of inside-quality inspection being conveyed on a conveyer is irradiated sideways with beams of light from projection lamps (21) being concentrated. Photo- detecting means (3) detects light transmitted through the object (F) irrespective of the size and thickness of the skin of the object (F) without being influenced by extraneous light. A white-level calibrating device (35) is provided to the photo-detecting means (3). The projection lamps (21) project and concentrate their beams of light onto one side of the object (F) in an inspection position (11) at different angles from different positions diagonally distributed from the oblique front to the oblique back. Fractions of light transmitted through the object (F) and emerging from the other side of the object (F) are condensed by a condenser lens (31). A shutter (33) for opening/closing the optical path is provided between a light-receiving window (313) of the condenser lens (31) and a light-inputting face (321) of an optical fiber for directing light to a spectrometer. The shutter (33) is operated when the inspection center of the object (F) passes the inspection position (11). A white-level calibrating plate (351) is moved to a position in front of the light-receiving window (313) and moved back so as to perform calibration. The deviation of the calibration curve is corrected by placing a quality reference material (361) in the same position and moving it back.
Patent NZ-515754-A (NZ)
Title: Bicyclic oxazolidinone compounds, pharmaceuticals thereof and their use as antibacterial agents
Inventor: GENIN MICHAEL J
IPC: A61P17/00
Filed: 2000-05-17
Abstract: Described is a compound of formula I, where: W is O or S; X is -S(=O)m-, or -NR3-; Y is -O-, -NH-, -CH2-, or -S(=O)m-; R1 is optionally substituted C1-4alkyl; R2 is H, C1-6alkyl that is optionally substituted with 1-3 halo, cyclopropyl, -OC1-4alkyl, -NH2, -NHC1-6alkyl, or -N(C1- 6alkyl)2; n is 0 or 1 with the proviso that where n is 0, Y is -CH2-. Also described is a pharmaceutical composition comprising the compound of formula I as defined above. The compound of formula I is useful for treating microbial infections.
Patent NZ-522868-A (NZ)
Title: A rotary parlour for milking of animals
Inventor: ERIKSSON MATTIAS
IPC: A01K1/12
Filed: 2001-05-31
Abstract: The invention relates to a rotary parlour for milking of animals. The parlour comprises a rotary platform (3) arranged to constitute a support surface for the animals, stalling means arranged to divide the platform (3) into stalls for receiving individual animals (1), driving means arranged to rotate the platform (3) and milking means (11) arranged to be attached to the animals (1). The platform (3) comprises a number of platform modules (8) each having a front edge (9) connected to a rear edge (10) of another platform module (8) at a determined angle of at least two possible angles in relation to each other in such a manner that the platform (3) obtains an annular extension having a size related to said determined angle.
Patent NZ-525337-A (NZ)
Title: Shutter device for closing an aperture
Inventor: COENRAETS BENOIT
IPC: E06B9/02
Filed: 2001-09-13
Abstract: Disclosed is a shutter device (1) in particular for closing an aperture (3) or the like, by displacement of the shutter (1) relative to one or several guide paths, wherein the transmission means co-operating with the guide paths, are provided between the lateral edges of the shutter (1) and the guide paths such that when a certain tractive force transverse to the longitudinal direction of the guide paths is exerted on the lateral edges of the shutter (1), said edges are separated at least partly from said transmission means.
Patent NZ-533513-A (NZ)
Title: Selective dopamine D3 receptor agonists for the treatment of sexual dysfunction
Inventor: VAN DER GRAAF PIETER HADEWIJN
IPC: A61K31/5375
Filed: 2002-12-10
Abstract: Disclosed is the use of a composition comprising a selective dopamine D3 inhibitor agonist, wherein said agonist is 15 times more functionally selective for a dopamine D3 receptor as compared with a dopamine D2 receptor, in the preparation of a medicament for the treatment of female sexual dysfunction, male erectile dysfunction, male anorgasmia or male hypoactive sexual desire disorder. Also disclosed are methods for identifying said agonists comprising the administration of the agonist to a non-human animal, stimulating the pelvic nerve and measuring changes in vaginal/clitoral blood flow, intracavernosal pressure and/or cavernosal blood flow.
Patent NZ-535020-A (NZ)
Title: Cigarette packet with hinged lid
Inventor: BRAY ANDREW JONATHAN
IPC: B65D25/20
Filed: 2003-03-11
Abstract: A hinged-lid cigarette pack is constructed to have an angle f between the back wall plane of the pack and the line extending from the hinge line 7 to the top edge 6 of the front wall of the pack of less than 30 degrees. The front wall top edge 6 and the bottom edge of the front of the lid 5 (which are generally coincident when the lid is closed) are both parallel to the plane of the bottom 10 of pack. This configuration uses the same amount of material as a "standard" pack, but allows more advertising area A at the top face of the inner frame 8 of the pack.
Patent NZ-545647-A (NZ)
Title: Combination neisserial compositions
Inventor: PIZZA MARIAGRAZIA
IPC: A61K38/16
Filed: 2000-05-19
Abstract: Disclosed are compositions comprising a first biological molecule from a Neisseria bacterium and a second biological molecule from a Neisseria bacterium. The term "biological molecule" includes proteins and nucleic acids. Preferred Neisseria species are N. meningitidis and N. gonorrhoeae. Also disclosed is the use of the composition as a medicament.
Patent NZ-552539-A (NZ)
Title: Drug conjugates selected from cetrizine, desloratidine, terfenadine, fexofenadine or pseudoephedrine linked through a cleavable disulphide linker
Inventor: SATYAM APPARAO
IPC: A61K31/496
Filed: 2005-08-26
Abstract: Disclosed are drug conjugates linked through a cleavable disulphide linker, wherein the compounds are represented by the general formula (I), wherein B represents a disulphide group (S-S); A and A1 independently represent a bond, (CH2)d, or a phenylene moiety; E represents a bond; D1 and D2 are independently selected from; cetrizine, desloratidine, terfenadine, fexofenadine and pseudoephedrine; and wherein the other substituents are as defined herein.
Patent NZ-556361-A (NZ)
Title: Tap assembly with overfill protection and level gauge
Inventor: SCHMITZ JEAN-CLAUDE
IPC: F16K1/30
Filed: 2006-01-10
Abstract: A tap with an overflow protection assembly 14 for a liquid gas cylinder 12 comprises a tap body 10 with a longitudinal axis and a base portion 16-1 used for securing the tap body 10 to the cylinder 12 opening, an overflow protection device 14 with a valve for controlling the flow of fluid into and out of the cylinder, and a level gauge 22 that indicates the level of liquid in the cylinder 12. The overflow protection device comprises the valve, an elongate support leg 24 secured to the tap body 10 such that it extends along the longitudinal axis of the tap body 10, a float lever 44 fixed to a float 42 with the float lever 44 connected to the support leg 24 at the free end 28 at a point distant from the tap body 10 and able to pivot along the longitudinal axis of the support leg 24 in response to movements of the float 42 due to liquid level variations in the cylinder 12, and a rod 18 extending along the support leg 24 to the valve. When the float lever 44 pivots to a position that indicates the liquid in the cylinder has reached the maximum level, the rod 18 will close the valve and stop filling of the cylinder 12. The level gauge 22 comprises an elongate gauge rod 20 placed outside of but extending alongside the support leg 24 from the free end 28 of the support leg 24 to the tap body 10 where it is received within and allowed reciprocating linear movement within a bore parallel to the longitudinal axis of the tap body 10, a crank 56 coupling the float lever 44 and rod 20 that longitudinally moves the rod in response to pivot motion of the float lever due to variations of liquid level in the cylinder 12, and a permanent magnet fixed to the other end of the gauge rod 20. The magnet moves linearly within the tap body 10 and magnetically actuates the indicator 16-3 of a liquid level display 22 mounted on the tap body. This design does not require electrical power for its operation.
Patent NZ-562226-A (NZ)
Title: Broadband land mobile antenna
Inventor: BABITSKY GENNADY
IPC: H01Q5/15
Filed: 2006-03-13
Abstract: Disclosed is a monopole antenna. The antenna includes a helical radiating element (126) including a first longitudinal portion having a first winding pitch (128) and a second longitudinal portion having a second winding pitch (130). The antenna also includes a cylindrical radiating element (134) generally coaxial with the helical radiating element and extending along at least most of the first longitudinal portion.
Patent NZ-570240-A (NZ)
Title: Wind turbine turns on approach lighting when a signal sent from the aircraft has a predetermined strength
Inventor: WOBBEN ALOYS
IPC: F03D11/00
Filed: 2007-02-12
Abstract: Disclosed is a wind turbine with approach lighting. At a predetermined distance from the turbine, a vehicle sends a predetermined signal to a receiver on the turbine. The light is activated in response to the signal, and is deactivated after a predetermine period of time and/or the strength of the signal falls below a predetermined value.
Patent NZ-572694-A (NZ)
Title: P38 inhibitors and methods of use thereof
Inventor: MUNSON MARK
IPC: A61K/
Filed: 2004-02-25
Abstract: Disclosed is a benzimidazole compound including resolved enantiomers, diastereoisomers, solvates and pharmaceutically acceptable salts thereof, said compound having the formula (I) wherein the substituents are defined in the specification. Also disclosed are compositions comprising said compound and the use of said compound in the manufacture of a medicament for the treatment of p38-mediated conditions.
Patent NZ-572915-A (NZ)
Title: Fungicidal azocyclic amides
Inventor: SHAPIRO RAFAEL
IPC: C07D401/04
Filed: 2007-07-27
Abstract: Disclosed herein are azocyclic amide compounds of formula 1, wherein the substitents along with provisos are defined within the specification, processes for their manufacture and fungicidal compositions comprising said compounds.
Patent NZ-583899-A (NZ)
Title: Process for the manufacure of a pharmaceutical product comprising citric acid, magnesium oxide, potassium bicarbonate and sodium picosulfate, pharmaceutical composition comprising granules obtained by such process and intermediate
Inventor: XU HAIJUN
IPC: A61K9/00
Filed: 2008-10-10
Abstract: Disclosed is a process for the preparation of a pharmaceutical composition wherein the composition includes a homogeneous mixture of citric acid, magnesium oxide, potassium bicarbonate and sodium picosulphate and, optionally, saccharin sodium and/or orange flavour, the process including the steps of: a) dry mixing citric acid and magnesium oxide using a means for forming a homogenous mixture of compounds with markedly different densities, in which the means for forming the homogenous mixture of compounds is a multi-dimension blender, a three-dimension blender or a bladeless and/or paddleless blender b) applying (e.g. spraying) a solution of sodium picosulphate onto the potassium bicarbonate; and drying said sodium picosulphate and potassium bicarbonate; and c) mixing at least a part of the product of step a) with at least a part of the product of step b) and, optionally, saccharin sodium and/or orange flavour. The use of the above mentioned pharmaceutical composition as a laxative is also disclosed. Also disclosed are pharmaceutical compositions comprising citric acid and magnesium oxide, sodium picosulphate and potassium bicarbonate as well as pharmaceutical compositions comprising all four components.